Increased prevalence of deep vein thrombosis and mortality in patients with Covid-19 at a referral center in Brazil

Abstract

Background Among the multiple complex pathophysiological mechanisms underlying Covid-19 pneumonia, immunothrombosis has been shown to play a key role. Objective The aim of the present study was to assess the monthly prevalence of deep venous thrombosis in a university hospital that admitted 5159 patients with Covid-19 in the medical ward and intensive care unit (ICU) and investigate whether there has been an increase in the prevalence of deep vein thrombosis and dead recently. Method A clinical trial was conducted evaluating 5159 patients admitted to the university hospital, Hospital de Base in São Jose do Rio Preto-Brazil, with a positive test for Covid-19, the prevalence of monthly deep venous thrombosis and the increase in thrombotic and events and mortality in March 2020 to April 2021 compared to the previous January and February with March–April of 2021. The evaluated by Fisher's exact test. Results The prevalence of deep vein thrombosis varied between the months of 0.26% to 7%, with an average of 2.5%. The months of March and April 2021 had a significant increase in venous thrombosis and mortality in relation to the months of January and February 2021. Conclusion The prevalence of deep venous thrombosis was variable during the months evaluated, since the beginning of Covid-19, but there was a significant increase in these last two months.

Mortality and Change in the Prevalence of Deep Vein Thrombosis Associated With SARS-CoV-2 P.1 Variant

“…The mortality rate was higher among those with DVT than those without DVT. Therefore, DVT is a factor associated with mortality in patients with COVID-19 [ 10 ].…”

A Comparison of the Financial Performance of Telecommunication Companies Listed on the Jakarta Islamic Index Before and Amidst the Covid-19 Pandemic

“…Therefore, service providers need to find solutions that can reduce investment costs in telecommunication networks to maintain their business continuity, and continue to provide quality data communication services at affordable prices for consumers. Based on the research that has been done [7] [8], network sharing provides some benefits to both telecommunications operators and consumers.…”

Aortic Thrombosis Associated with Three Types of COVID-19 Vaccine

“…An association has been detected with a state of hypercoagulability, and the risk of developing venous and arterial thromboembolic events is as high as 31% [ 6 ]. The Gamma variant has also been described as one of the most thrombogenic variants of COVID-19 [ 3 , 7 ]. There are also warnings that the adenovirus vector vaccine ChAdOx1 nCoV-19 can result in the rare development of immune thrombotic thrombocytopenia mediated by platelet-activating antibodies against PF4, which clinically mimics autoimmune heparin-induced thrombocytopenia [ 8 , 9 ].…”

“…Arterial and venous thromboses associated with COVID-19 have been reported in the literature [2][3][4][5]. An association has been detected with a state of hypercoagulability, and the risk of developing venous and arterial thromboembolic events is as high as 31% [6].…”